Products | Implantable Cardiac Monitor (ICM) | August 11, 2015

BioMonitor

Related Content

The LUX-Dx II+ ICM System product design
News | Implantable Cardiac Monitor (ICM)
Boston Scientific launches LUX-Dx II+ Insertable Cardiac Monitor System

October 3, 2023 -- Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation ...

Home October 03, 2023
Home
Rapid adoption of wireless cardiac monitoring devices and continuous advancements in remote monitoring technology are generating significant business opportunities for companies in the cardiovascular diagnostic and monitoring devices market
Feature | Implantable Cardiac Monitor (ICM)
Cardiovascular Diagnostic and Monitoring Devices Market to Cross $29B by 2031

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...

Home June 13, 2023
Home
Assert-IQ\ ICM is the world’s longest lasting Bluetooth - enabled insertable cardiac monitor
News | Implantable Cardiac Monitor (ICM)
Abbott Receives FDA Clearance for Assert-IQ Insertable Cardiac Monitor 

May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug ...

Home May 18, 2023
Home
Transaction values Avertix at an enterprise value of $195 million
News | Implantable Cardiac Monitor (ICM)
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

May 4, 2023 — Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long ...

Home May 04, 2023
Home
Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring (i.e., Holter monitors and 30-day external monitors) may not be optimally managed for recurrent stroke prevention versus those who received continuous monitoring with insertable cardiac monitors.
News | Implantable Cardiac Monitor (ICM)
New Simulation Data From the STROKE AF Study Shows Insertable Cardiac Monitors Detect 4 Times More AF than Intermittent Monitoring
April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...
Home April 29, 2022
Home
Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).
News | Implantable Cardiac Monitor (ICM)
Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
Home April 06, 2022
Home
The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.
News | Implantable Cardiac Monitor (ICM)
Implantable Cardiac Monitors Predict Complications in Selected Post-myocardial Infarction Patients

September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of ...

Home September 07, 2021
Home
BioMonitor IIIm is a miniature electrocardiogram (ECG) device which records, stores and transmits clinical data that is integral in the diagnosis and long-term monitoring of cardiac patients, with maximum precision and for an extended period of time.
News | Implantable Cardiac Monitor (ICM)
Biotronik Implantable Cardiac Monitor Receives Prestigious Industry Award

August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...

Home August 09, 2021
Home
Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal Linq Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care.
News | Implantable Cardiac Monitor (ICM)
Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care

June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...

Home July 14, 2021
Home
With the FDA clearance of the Vital Data Sensor, Biotronik's Biomonitor IIIm features two-in-one detection, providing physicians the ability to monitor for early signs of potential life-threatening cardiac arrhythmias and body temperature increases potentially associated with fever.
News | Implantable Cardiac Monitor (ICM)
FDA Clears Fever-Detecting Cardiac Monitor From Biotronik

December 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared Biotronik's Vital Data Sensor, which identifies ...

Home December 22, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now